Outcome of Board Meeting inter-alia to consider and approve un-audited Standalone and Consolidated Financial Results for the second quarter and half-year ended September 30, 2025.
BNAGROCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BN Agrochem's board, meeting on November 13, 2025, approved its unaudited standalone and consolidated results for Q2 FY26 and the half-year ended September 30, 2025. On a standalone basis, Q2 net profit jumped sharply to Rs. 1,795.58 lacs from just Rs. 31.38 lacs in Q2 FY25, and the company swung from a first-half loss of Rs. 5,963.31 lacs in H1 FY25 to a profit of Rs. 1,817.02 lacs in H1 FY26. Total assets stood at Rs. 70,265.33 lacs with total equity of Rs. 44,405.71 lacs on a consolidated basis. Results include three subsidiaries in Europe, Singapore, and Liberia. Statutory auditor JSMG & Associates issued an unmodified (clean) limited review opinion on both standalone and consolidated numbers. Consolidated operating cash flow for the half-year was a small outflow of Rs. 52.22 lacs.
Strong standalone profit recovery from a prior-year loss and a big jump in Q2 earnings are positive signals for shareholders and should support sentiment on the stock. The slight operating cash outflow on a consolidated half-year basis is a minor watchpoint but is small relative to the reported profit turnaround.